1. Home
  2. KNSA vs NOG Comparison

KNSA vs NOG Comparison

Compare KNSA & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • NOG
  • Stock Information
  • Founded
  • KNSA 2015
  • NOG 2006
  • Country
  • KNSA United Kingdom
  • NOG United States
  • Employees
  • KNSA N/A
  • NOG N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • NOG Oil & Gas Production
  • Sector
  • KNSA Health Care
  • NOG Energy
  • Exchange
  • KNSA Nasdaq
  • NOG Nasdaq
  • Market Cap
  • KNSA 2.6B
  • NOG 2.6B
  • IPO Year
  • KNSA 2018
  • NOG N/A
  • Fundamental
  • Price
  • KNSA $38.51
  • NOG $24.76
  • Analyst Decision
  • KNSA Strong Buy
  • NOG Buy
  • Analyst Count
  • KNSA 7
  • NOG 8
  • Target Price
  • KNSA $44.00
  • NOG $31.14
  • AVG Volume (30 Days)
  • KNSA 392.4K
  • NOG 2.1M
  • Earning Date
  • KNSA 10-28-2025
  • NOG 11-04-2025
  • Dividend Yield
  • KNSA N/A
  • NOG 7.26%
  • EPS Growth
  • KNSA N/A
  • NOG 6.84
  • EPS
  • KNSA 0.07
  • NOG 6.08
  • Revenue
  • KNSA $529,332,000.00
  • NOG $2,094,039,000.00
  • Revenue This Year
  • KNSA $37.21
  • NOG $18.65
  • Revenue Next Year
  • KNSA $12.07
  • NOG N/A
  • P/E Ratio
  • KNSA $582.26
  • NOG $4.08
  • Revenue Growth
  • KNSA 56.18
  • NOG 6.25
  • 52 Week Low
  • KNSA $17.82
  • NOG $19.88
  • 52 Week High
  • KNSA $39.12
  • NOG $44.31
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 64.65
  • NOG 44.45
  • Support Level
  • KNSA $37.69
  • NOG $24.04
  • Resistance Level
  • KNSA $38.83
  • NOG $25.90
  • Average True Range (ATR)
  • KNSA 0.95
  • NOG 0.92
  • MACD
  • KNSA 0.00
  • NOG -0.13
  • Stochastic Oscillator
  • KNSA 79.11
  • NOG 15.19

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

Share on Social Networks: